1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
7Bruix J,Sherman M. Practice Guidelines Committee,American Association for the study of Liver Diseases.Management of hepatocellular carcinoma[J].Hepatology,2005,(05):1208-1236.doi:10.1002/hep.20933.
8Canana C,Schepis F,Orlando A. Transarterial chemoembolization for unresectable hepatocellular carcinoma:meta-analysis of randomised controlled trials[J].RADIOLOGY,2002,(01):47-54.doi:10.1148/radiol.2241011262.
9Llovet JM,Bruix J. Systematic review of randomised trials for unresectable hepatocellular carcinoma:Chemoembolization improves survival[J].Hepatology,2003,(02):429-442.doi:10.1053/jhep.2003.50047.
10Attallah AM,Tabu AA,El-Sadany M. Dysregulation of blood lymphocyte subsets.$and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma[J].Clinical and Experimental Medicine,2003,(03):181-185.
